Background: The prognostic significance of focal adhesion kinase (FAK) in breast cancer remains controversial. Here, we conducted a meta-analysis to explore the prognostic value of FAK expression in breast cancer.
Materials and methods: Possible prognostic significance of protein or mRNA expression of FAK in breast cancer was investigated with searches of electronic databases for relevant publications. Pooled hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) were extracted from eligible studies.
Results: A total of eight eligible studies which included 2604 participants were analyzed in this meta-analysis. Increased expression of FAK protein was found to significantly correlate with shorter overall survival (OS) (HR = 1.43, 95% CI: 1.12-1.83; P = 0.004), and not with disease-free survival (HR = 1.31, 95% CI: 0.92-1.85; P = 0.14). Elevated FAK protein expression was also associated with negative estrogen receptor (ER) expression (OR, 1.34; 95% CI, 1.06-1.68; P = 0.01), negative progesterone receptor (PR) expression (OR, 1.54; 95% CI, 1.22-1.93; P < 0.001), positive human epidermal growth factor receptor 2 (HER2) expression (OR, 1.64; 95% CI, 1.28-2.09; P < 0.001), triple-negative breast cancer (TNBC) (OR, 1.57; 95% CI, 1.14-2.17; P = 0.006), high nuclear grade (OR, 1.70; 95% CI, 1.05-2.78; P = 0.03), high Ki-67 expression level (OR, 2.87; 95% CI, 1.94-4.24; P < 0.001), and positive p53 status (OR, 2.28; 95% CI, 1.58-3.29; P < 0.001).
Conclusion: Our meta-analysis identifies an association between increased FAK protein expression and worse OS among breast cancer patients. Moreover, enhanced FAK expression is associated with negative ER expression, negative PR expression, positive HER2 expression, TNBC, high nuclear grade, high Ki-67 expression level, and positive p53 status in breast carcinoma.
Keywords: Breast cancer; FAK; Meta-analysis; Prognosis; Survival.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.